Most Popular

M & A Deals | M & A League Table | Real Assets | Sector Events |  Private Capital Conference

UK: Silence prices upsized US$175m ADS offering

Life Sciences Nick Herbert -
Silence Therapeutics, a global clinical-stage biotechnology company developing novel short interfering RNA (siRNA) therapies, has priced its previously announced underwritten public offering of 12,962,963 ADS, each representing three ordinary shares of £0.05 each, at US$13.50 per ADS. There is also a 30-day option for the underwriters to purchase up...

Italy: Giellepi takes controlling stake in Pet Care Group

Animal Health Nick Herbert -
Giellepi, an Italy-based developer and supplier of ingredients to the wellness and nutrition industry, has entered into a strategic partnership with Integropet, an Italian e-commerce brand specialising in natural supplements and probiotics for dogs and cats. The transaction sees Giellepi take a controlling stake in Pet Care Group, owner of Integropet, in support of strengthening Integropet's e-commerce operations and expand into retail and pharmacy channels. VCF, the Italian partner of ACS Partners, led by Nicoló Venturi and Nicola Verzura, was exclusive financial advisor to Pet Care Group. Nobel Partners supported Giellepi.